CA9 and neoplasm: We optimized theuse of [111In]In-MSC3 for preclinical imaging such thatit can be applied in syngeneic mouse models and showed that we canquantitatively distinguish between tumor models with varying CAIX+ fractions by ex vivo analyses and in vivo mCAIX microSPECT/CT.